The incidence of pseudotumour in metal-on-metal hip resurfacing and the results of a screening tool for patient recall
Erturan G., Taylor A., Barker K., Masterson S., Marsh R., Beard D., McLardy-Smith P., Gibbons M., Carr A., Glyn-Jones S.
© 2013 EFORT. All rights are reserved. Metal-on-metal hip resurfacing arthroplasty (MoMHRA) was introduced in 1997 and has become an established surgical option, especially for younger patients with end-stage osteoarticular disease (Daniel et al. 2011). Designer and non-designer data continue to support the use of MoMHRA for this cohort of patients despite pseudotumour becoming an acknowledged complication (Murray et al. 2012; Treacy et al. 2011). The rates of pseudotumour are variable, and concern amongst the general public, healthcare providers and government is increasing together with the potential revision burden on hip services particularly compounded by poor reported outcomes post-revision (Glyn-Jones et al. 2009; Pandit et al. 2008; Hart et al. 2009; Kwon et al. 2011; Grammatopolous et al. 2009; Carrothers et al. 2010).